InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Tzianabos Arthur, 董事长兼首席执行官. Director active across 4 companies, notably Homology Medicines, Inc.. Aggregated, 8 disclosures have been logged. Split: 0 buy · 1 sell. Total volume traded: €14k. Activity tracked since 9 January 2023. The latest transaction was disclosed on 10 March 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
TZIANABOS ARTHUR is Président-Directeur Général. The file shows 8 filings, and across the 8 sampled filings between 2022-01-12 and 2026-03-12, sales total EUR 13852 and the most common transaction type is option exercise.